PL1633365T3 - Makrocykliczne pochodne chinazoliny jako środki przeciwproliferacyjne - Google Patents

Makrocykliczne pochodne chinazoliny jako środki przeciwproliferacyjne

Info

Publication number
PL1633365T3
PL1633365T3 PL04739341T PL04739341T PL1633365T3 PL 1633365 T3 PL1633365 T3 PL 1633365T3 PL 04739341 T PL04739341 T PL 04739341T PL 04739341 T PL04739341 T PL 04739341T PL 1633365 T3 PL1633365 T3 PL 1633365T3
Authority
PL
Poland
Prior art keywords
antiproliferative agents
quinazoline derivatives
macrocyclic quinazoline
macrocyclic
derivatives
Prior art date
Application number
PL04739341T
Other languages
English (en)
Inventor
Eddy Jean Edgard Freyne
Timothy Pietro Suren Perera
Peter Jacobus Johannes Antonius Buijnsters
Marc Willems
Gaston Stanislas Marcella Diels
Werner Constant Johan Embrechts
Holte Peter Ten
Frederk Jan Rita Rombouts
Carsten Schulz-Fademrecht
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33493782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1633365(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL1633365T3 publication Critical patent/PL1633365T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/93—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL04739341T 2003-05-27 2004-05-25 Makrocykliczne pochodne chinazoliny jako środki przeciwproliferacyjne PL1633365T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP0305723 2003-05-27
EP0310266 2003-09-15
EP0351061 2003-12-18
EP04739341A EP1633365B1 (en) 2003-05-27 2004-05-25 Macrocyclic quinazoline derivatives as antiproliferative agents
PCT/EP2004/005621 WO2004105765A1 (en) 2003-05-27 2004-05-25 Macrocyclic quinazoline derivatives as antiproliferative agents

Publications (1)

Publication Number Publication Date
PL1633365T3 true PL1633365T3 (pl) 2012-07-31

Family

ID=33493782

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04739341T PL1633365T3 (pl) 2003-05-27 2004-05-25 Makrocykliczne pochodne chinazoliny jako środki przeciwproliferacyjne

Country Status (31)

Country Link
US (4) US7648975B2 (pl)
EP (2) EP2305687A1 (pl)
JP (1) JP4887151B2 (pl)
KR (1) KR101143878B1 (pl)
CN (1) CN102718775B (pl)
AR (2) AR045687A1 (pl)
AT (1) ATE544454T1 (pl)
AU (1) AU2004243487B2 (pl)
BR (1) BRPI0410714B8 (pl)
CA (1) CA2525214C (pl)
CL (1) CL2004001267A1 (pl)
CO (1) CO5640038A2 (pl)
CY (1) CY1113002T1 (pl)
DK (1) DK1633365T3 (pl)
EA (1) EA009064B1 (pl)
ES (1) ES2381976T3 (pl)
HR (1) HRP20120351T1 (pl)
IL (3) IL172154A0 (pl)
IS (1) IS3030B (pl)
JO (1) JO2785B1 (pl)
MX (1) MXPA05012762A (pl)
MY (1) MY148633A (pl)
NO (1) NO334209B1 (pl)
NZ (1) NZ544154A (pl)
PA (1) PA8603801A1 (pl)
PL (1) PL1633365T3 (pl)
PT (1) PT1633365E (pl)
SI (1) SI1633365T1 (pl)
TW (3) TWI379835B (pl)
UA (1) UA84010C2 (pl)
WO (1) WO2004105765A1 (pl)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8603801A1 (es) * 2003-05-27 2004-12-16 Janssen Pharmaceutica Nv Derivados de la quinazolina
US20050192314A1 (en) * 2003-11-13 2005-09-01 Ambit Biosciences Corporation Urea derivatives as C-kit modulators
UA83881C2 (en) 2003-12-18 2008-08-26 Янссен Фармацевтика Н.В. Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents
ATE446750T1 (de) * 2003-12-18 2009-11-15 Janssen Pharmaceutica Nv 3-cyano-chinolin-derivate mit antiproliferativer wirkung
MY169441A (en) 2004-12-08 2019-04-11 Janssen Pharmaceutica Nv 2,4, (4,6) pyrimidine derivatives
NI200700147A (es) 2004-12-08 2019-05-10 Janssen Pharmaceutica Nv Derivados de quinazolina inhibidores de cinasas dirigidos a multip
JO3088B1 (ar) * 2004-12-08 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف
KR100910333B1 (ko) 2005-02-23 2009-07-31 시오노기세이야쿠가부시키가이샤 타이로신 키나아제 억제 활성을 갖는 퀴나졸린 유도체
GB0509227D0 (en) * 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Intracellular enzyme inhibitors
WO2007003525A2 (en) * 2005-06-30 2007-01-11 Janssen Pharmaceutica N.V. Cyclic anilino-pyridinotriazines as gsk-3 inhibitors
CA2654583C (en) * 2006-07-13 2015-11-24 Janssen Pharmaceutica N.V. Mtki quinazoline derivatives
JP2009242240A (ja) * 2006-08-04 2009-10-22 Mebiopharm Co Ltd 含ホウ素キナゾリン誘導体
CN101535279B (zh) 2006-09-11 2015-05-20 柯瑞斯公司 含锌结合基的喹唑啉基egfr抑制剂
AU2007296745B2 (en) * 2006-09-11 2011-12-01 Curis, Inc. Quinazoline based EGFR inhibitors
US7547781B2 (en) 2006-09-11 2009-06-16 Curis, Inc. Quinazoline based EGFR inhibitors containing a zinc binding moiety
EP2101782A2 (en) * 2006-10-27 2009-09-23 Janssen Pharmaceutica N.V. Use of mtki 1 for treating or preventing bone cancer
CA2664148A1 (en) * 2006-10-27 2008-05-02 Janssen Pharmaceutica Nv Vegfr3 inhibitors
EP2089710B1 (en) * 2006-10-27 2014-10-01 Janssen Pharmaceutica NV A method for pharmacologically profiling compounds
AU2007310842A1 (en) * 2006-10-27 2008-05-02 Janssen Pharmaceutica Nv Use of a MT kinase inhibitor for treating or preventing brain cancer
JPWO2008087736A1 (ja) * 2007-01-19 2010-05-06 宇部興産株式会社 アラルキルオキシ又はヘテロアラルキルオキシ基を有する芳香族アミンの製法
US8642067B2 (en) 2007-04-02 2014-02-04 Allergen, Inc. Methods and compositions for intraocular administration to treat ocular conditions
ES2562218T3 (es) 2007-07-27 2016-03-03 Janssen Pharmaceutica, N.V. Pirrolopirimidinas útiles para el tratamiento de enfermedades proliferativas
US8119616B2 (en) 2007-09-10 2012-02-21 Curis, Inc. Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety
CL2008003384A1 (es) * 2007-11-14 2009-12-11 Enanta Pharm Inc Compuestos derivados de quinoxalina macrocíclica, inhibidores de serina proteasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de la hepatitis c.
US8426430B2 (en) 2008-06-30 2013-04-23 Hutchison Medipharma Enterprises Limited Quinazoline derivatives
PT2350075E (pt) 2008-09-22 2014-06-09 Array Biopharma Inc Compostos imidazo[1,2b]piridazina substituídos como inibidores da trk cinase
AR074052A1 (es) 2008-10-22 2010-12-22 Array Biopharma Inc Compuestos pirazolo{1,5-a}pirimidina sustituida como inhibidores de trk cinasa
US8765727B2 (en) 2009-01-23 2014-07-01 Incyte Corporation Macrocyclic compounds and their use as kinase inhibitors
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
TWI406853B (zh) * 2010-04-07 2013-09-01 Dev Center Biotechnology Ｅｇｆｒ與ｖｅｇｆｒ－２雙重抑制劑及其用途與製法
NZ604708A (en) 2010-05-20 2015-05-29 Array Biopharma Inc Macrocyclic compounds as trk kinase inhibitors
WO2013126015A1 (en) 2012-02-23 2013-08-29 N. V. Nutricia Composition comprising non- digestible oligosaccharides
HUE034118T2 (en) * 2012-03-06 2018-01-29 Pfizer Macrocyclic derivatives for the treatment of proliferative diseases
CN104513253A (zh) * 2013-10-01 2015-04-15 南京波尔泰药业科技有限公司 用于治疗增殖性疾病的大环化合物
RU2733405C2 (ru) * 2014-02-07 2020-10-01 Экзитера Фармасьютикалз Инк. Терапевтические соединения и композиции
MA39823A (fr) 2014-04-03 2018-01-09 Janssen Pharmaceutica Nv Dérivés de pyridine macrocyclique
MA39822A (fr) 2014-04-03 2018-02-06 Janssen Pharmaceutica Nv Dérivés de pyrimidine bicycle
HUE061448T2 (hu) 2014-11-16 2023-07-28 Array Biopharma Inc (S)-N-(5-((R)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-A]pirimidin-3-il) -3-hidroxipirrolidin-1-karboxamid-hidrogénszulfát kristályos formája
KR20180086187A (ko) 2015-10-05 2018-07-30 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 자가포식 유동의 활성체 및 포스포리파제 d 및 타우를 포함하는 단백질 응집물의 클리어런스 및 단백질질환의 치료
CN108697708A (zh) 2015-10-26 2018-10-23 洛克索肿瘤学股份有限公司 Trk抑制剂抗性癌症中的点突变以及与此相关的方法
WO2017148925A1 (en) 2016-02-29 2017-09-08 Oncodesign Sa Radiolabeled macrocyclic egfr inhibitor
ES2987474T3 (es) 2016-04-04 2024-11-15 Loxo Oncology Inc Formulaciones líquidas de (S)-N-(5-((R)-2-(2,5-difluorofenil)-pirrolidin-1-IL)-pirazolo[1,5-A]pirimidin-3-IL)-3-hidroxipirrolidina-1-carboxamida
US10045991B2 (en) 2016-04-04 2018-08-14 Loxo Oncology, Inc. Methods of treating pediatric cancers
ES2836222T3 (es) 2016-05-18 2021-06-24 Loxo Oncology Inc Preparación de (S)-N-(5-((R)-2-(2,5-difluorofenil)pirrolidin-1-il)pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida
JOP20190092A1 (ar) 2016-10-26 2019-04-25 Array Biopharma Inc عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
PL3720438T3 (pl) 2017-12-07 2024-03-18 Amplyx Pharmaceuticals, Inc. Heterocyklicznie podstawione pochodne pirydyny jako środki przeciwgrzybicze
CN112638371A (zh) 2018-06-25 2021-04-09 安普利克斯制药公司 被杂环和氨基取代的吡啶衍生物
UA129879C2 (uk) * 2020-01-31 2025-08-27 Онкодизайн Пресіжн Медісін (Опм) Макроциклічні інгібітори rip2-кінази
WO2021216440A1 (en) * 2020-04-20 2021-10-28 Tenova Pharmaceuticals Inc. Novel protein kinase inhibitors
IL313548A (en) 2021-12-16 2024-08-01 Kinnate Biopharma Inc MET kinase inhibitors
WO2024017258A1 (zh) * 2022-07-19 2024-01-25 百极弘烨(南通)医药科技有限公司 Egfr小分子抑制剂、含其的药物组合物及其用途
WO2026008023A1 (zh) * 2024-07-04 2026-01-08 正大天晴药业集团股份有限公司 哒嗪胺类化合物及其医药用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE558251A (pl) 1956-06-11
DE2423536A1 (de) * 1974-05-15 1975-11-27 Bayer Ag 3-amino-phenylessigsaeure-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
NZ181256A (en) * 1975-07-21 1978-04-28 Janssen Pharmaceutica Nv 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives
US4110333A (en) 1976-05-17 1978-08-29 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
US5721237A (en) 1991-05-10 1998-02-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
GB9510757D0 (en) * 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
HU228446B1 (en) 1996-04-12 2013-03-28 Warner Lambert Co Kinazoline derivatives as irreversible inhibitors of protein-kinase, pharmaceutical compositions containing these compounds and use thereof
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
ATE232205T1 (de) 1998-10-01 2003-02-15 Astrazeneca Ab Chinolin- und chinazolin derivate und ihre verwendung als inhibitoren von krankheiten, bei denen cytokine beteiligt wird
FR2809400B1 (fr) * 2000-05-25 2004-04-09 Inst Francais Du Petrole Materiaux comportant des groupements organiques contenant du soufre et du phosphore lie par l'intermediaire d'atomes d'oxygenes a un oxyde mineral
PA8603801A1 (es) * 2003-05-27 2004-12-16 Janssen Pharmaceutica Nv Derivados de la quinazolina
JO3088B1 (ar) * 2004-12-08 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف

Also Published As

Publication number Publication date
NZ544154A (en) 2009-01-31
TW201245160A (en) 2012-11-16
CA2525214A1 (en) 2004-12-09
AR045687A1 (es) 2005-11-09
EP1633365A1 (en) 2006-03-15
JO2785B1 (en) 2014-03-15
US20100105668A1 (en) 2010-04-29
AR092137A2 (es) 2015-03-25
TWI379835B (en) 2012-12-21
CN102718775B (zh) 2016-02-17
JP2007504276A (ja) 2007-03-01
TWI468372B (zh) 2015-01-11
MXPA05012762A (es) 2006-02-13
PT1633365E (pt) 2012-05-07
CA2525214C (en) 2012-11-27
HRP20120351T1 (hr) 2012-05-31
IS8077A (is) 2005-10-14
IL172154A0 (en) 2006-04-10
SI1633365T1 (sl) 2012-06-29
EA009064B1 (ru) 2007-10-26
IL233046A0 (en) 2014-07-31
US20060247237A1 (en) 2006-11-02
NO334209B1 (no) 2014-01-13
ES2381976T3 (es) 2012-06-04
US20130178624A1 (en) 2013-07-11
PA8603801A1 (es) 2004-12-16
TWI468397B (zh) 2015-01-11
IL233045B (en) 2018-07-31
TW200510431A (en) 2005-03-16
CL2004001267A1 (es) 2005-04-22
IS3030B (is) 2021-06-15
JP4887151B2 (ja) 2012-02-29
US9273013B2 (en) 2016-03-01
US7648975B2 (en) 2010-01-19
IL233045A0 (en) 2014-07-31
DK1633365T3 (da) 2012-05-14
BRPI0410714B1 (pt) 2019-09-24
UA84010C2 (en) 2008-09-10
KR20060014415A (ko) 2006-02-15
EA200501866A1 (ru) 2006-06-30
EP2305687A1 (en) 2011-04-06
CY1113002T1 (el) 2016-04-13
ATE544454T1 (de) 2012-02-15
US8394786B2 (en) 2013-03-12
HK1176350A1 (zh) 2013-07-26
WO2004105765A1 (en) 2004-12-09
EP1633365B1 (en) 2012-02-08
KR101143878B1 (ko) 2012-05-24
CN102718775A (zh) 2012-10-10
US20160207938A1 (en) 2016-07-21
MY148633A (en) 2013-05-15
BRPI0410714A (pt) 2006-06-13
BRPI0410714B8 (pt) 2021-05-25
AU2004243487A1 (en) 2004-12-09
NO20056196L (no) 2005-12-28
TW201245111A (en) 2012-11-16
CO5640038A2 (es) 2006-05-31
AU2004243487B2 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
IL233046A0 (en) Quinazoline macrocyclic derivatives as antiproliferative agents
IL174533A0 (en) Quinazoline derivatives as antiproliferative agents
IL174534A0 (en) Quinazoline derivatives
GB0321648D0 (en) Quinazoline derivatives
IL174284A0 (en) Quinazoline derivatives
IL174257A0 (en) Quinazoline derivatives
GB0215823D0 (en) Quinazoline derivatives
PT1847539E (pt) Derivados de quinazolina
GB0317665D0 (en) Qinazoline derivatives
PL378245A1 (pl) Pochodne pirolopirydazyny
PL1682493T3 (pl) Pochodne amidoacetonitrylu
PL1606277T3 (pl) Pochodne imidazol-4-iloetynylo-pirydyny
IL174390A0 (en) Quinazoline derivatives
IL175421A0 (en) Quinazoline derivatives
GB0330002D0 (en) Quinazoline derivatives
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
ZA200603039B (en) Quinazoline derivatives
PL374817A1 (pl) Pochodne chinazoliny
GB0319793D0 (en) Pyridinylmorpholine derivatives
GB0321620D0 (en) Quinazoline derivatives
HK1091203A (en) Quinazoline derivatives as antiproliferative agents
GB0322535D0 (en) Quinazoline derivatives
GB0322534D0 (en) Quinazoline derivatives
GB0322458D0 (en) Quinazoline derivatives
GB0322410D0 (en) Quinazoline derivatives